Windtree Therapeutics, Inc. (Formerly Known As Discovery Laboratories, Inc.)
2600 Kelly Road
Warrington
Pennsylvania
18976
United States
Tel: 215-488-9300
Fax: 215-488-9301
Website: http://www.discoverylabs.com/
409 articles about Windtree Therapeutics, Inc. (Formerly Known As Discovery Laboratories, Inc.)
-
FDA Declines to Approve Discovery Laboratories's Lung Drug
4/20/2009
-
Discovery Laboratories Provides Update Regarding Surfactant Aerosol Generation Technology
4/14/2009
-
Discovery Laboratories to Highlight Respiratory Pipeline at the Future Leaders in the Biotech Industry Conference
3/30/2009
-
Discovery Laboratories Advances KL4 Surfactant Technology Platform With Lyophilized Formulation
3/26/2009
-
Discovery Laboratories Reports Fourth Quarter 2008 Financial Results
3/13/2009
-
Discovery Laboratories' Surfaxin(r) Phase 2 BPD Clinical Trial Results Published in Pediatrics
1/5/2009
-
Discovery Laboratories Secures $25 Million Committed Equity Financing Facility
12/15/2008
-
Discovery Laboratories to Present At the Lazard Healthcare Conference
11/13/2008
-
FDA Establishes Target Action Date of April 17, 2009 for Potential Approval of Discovery Laboratories' Surfaxin
11/10/2008
-
Discovery Laboratories Reports Third Quarter 2008 Financial Results
11/4/2008
-
Discovery Laboratories Reports That It Has Not Yet Received FDA Notification Regarding Complete Response
11/4/2008
-
Discovery Laboratories KL-4 Surfactant Data Presented At Two Key Medical Meetings
10/29/2008
-
Discovery Laboratories Submits Complete Response to May 2008 FDA Approvable Letter for Surfaxin(r) for RDS
10/20/2008
-
Discovery Laboratories to File Surfaxin Response in 4 Weeks
9/24/2008
-
Discovery Laboratories Reports Technical Achievements Towards Gaining FDA Approval of Surfaxin
9/24/2008
-
Discovery Laboratories' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
9/3/2008
-
Discovery Laboratories Reports Second Quarter 2008 Financial Results
8/6/2008
-
Discovery Laboratories Reports Progress in Responding to Surfaxin FDA Approvable Letter
8/6/2008
-
Discovery Laboratories Announces Second Quarter Conference Call and Webcast
7/31/2008
-
Discovery Laboratories KL-4 Surfactant Anti-Inflammatory Data Published in Pediatric Research
7/29/2008